Hyperbulia: Excessive activity and increased motivation, causes

Hyperbulia is a descriptive psychopathological term denoting an inflated drive and urge to act: a person experiences an increased "urge" for activity, food, sex, shopping, gambling, or other activities, accompanied by disinhibition and decreased self-control. In modern diagnostics, hyperbulia is not considered a standalone diagnosis: it is a symptom or syndrome associated with other conditions—primarily a manic episode in bipolar disorder, certain neurodegenerations (e.g., the behavioral variant of frontotemporal degeneration), and drug-induced impulse-control disorders (e.g., those associated with dopamine agonists). This approach helps to correctly codify the case and select treatment. [1]

Clinically, hyperbulia manifests as "too much intention and energy": rapid task switching, obsessive goal-orientation, abrupt decisions, and a sense of "must do it now." Behavioral manifestations include increased goal-directed activity, impulsive spending, risky behavior, and obsessive attempts to immediately fulfill desires. It's important to distinguish hyperbulia from simply high motivation: with hyperbulia, inhibitions are lost, criticism suffers, and the risk of consequences increases. [2]

Where does this "overheating" of motivation come from? The mechanisms vary across different nosologies, but the common denominator is a shift in the reward and inhibition systems. In mania, this is part of the affective pole (elevated mood and/or irritability plus sharply increased goal-directed activity); in frontotemporal degeneration, it is behavioral disinhibition and hyperorality; and in dopaminergic therapy, it is pathological sensitization of "want" with impulse control. [3]

Why is it important to call a spade a spade? Because treatment depends on the underlying cause. "Hyperbulia" as a label doesn't suggest therapy; however, "mania," "behavioral variant of FTD," or "medication-induced impulse control disorder" do. In practice, this saves months of searching for a "magic pill" and reduces the likelihood of legal and financial problems associated with impulsive behavior. [4]

Code according to ICD-10 and ICD-11

In ICD-10, hyperbulia as a symptom does not have a separate code. It most often occurs within F30-F31: F30.* "Manic episode" and F31.* "Bipolar affective disorder." If prolonged mood elevation/irritability with increased goal-directed activity is the predominant symptom, F30.* is coded based on severity and the presence of psychotic symptoms. If secondary causes (e.g., dementia or drug effects) are present, the underlying condition is coded with the appropriate modifiers. [5]

In ICD-11, the key categories are: 6A60 "Bipolar I disorder" (which includes manic episodes) and the corresponding clinical descriptions of mania/hypomania; for drug-induced cases - 6E66 "Secondary impulse-control disorder", when impulsive and overly motivated behavior is a direct consequence of a medical condition or treatment (e.g., dopamine agonists). For neurodegenerations, the categories of the corresponding dementias are used, indicating behavioral features. [6]

Table 1. How to codify “hyperbulia” in real practice

Clinical situation	ICD-10 (example)	ICD-11 (example)	Comment
Manic episode with increased goal-directed activity	F30.*	6A60 (manic episode in BAR-I)	The symptom "hyperbulia" is part of the criteria for mania. [7]
Drug-induced excessive "attraction" (gambling, hypersexuality, etc.)	Underlying somatic condition + external causes	6E66 "secondary impulse control disorder syndrome"	Often in the background of dopamine agonists. [8]
Behavioral disinhibition in frontotemporal degeneration	F02.* + clarification	Dementia (bvFTD) with behavioral symptoms	Frequent hyperorality, impulsivity. [9]

Epidemiology

Hyperbulia is not considered a standalone diagnosis, so prevalence is assessed using baseline conditions. Manic episodes occur within the bipolar spectrum; lifetime prevalence estimates for bipolar I disorder range from 1-2% in various surveys, with mania defined as "abnormally increased activity/energy." A significant proportion of patients first experience mania at a young age, but episodes are also possible later. [10]

Behavioral variant frontotemporal degeneration (bvFTD) is a common cause of pathological disinhibition in the elderly. It is characterized by impaired social control, impulsivity, hyperorality, and changes in eating behavior, with relatively preserved memory in the early stages. The prevalence of bvFTD among dementias under 65 is higher than that of Alzheimer's disease, and it is often disinhibition that brings patients to the doctor. [11]

A separate large group is drug-induced impulse control disorders in patients receiving dopamine agonists (for example, for Parkinson's disease or prolactinoma). Meta-analyses and large reviews confirm a link with pathological gambling, hypersexuality, compulsive buying, and overeating; the risk is particularly high with drugs with affinity for D3 receptors (pramipexole, ropinirole). This is a typical "portrait" of clinical hyperbulia of drug origin. [12]

Finally, an important practical implication: since hyperbulia occurs as a cross-sectional symptom in different systems, screening should be targeted—for mania/hypomania, for behavioral signs of FTD in the elderly, and for medication factors in patients undergoing dopaminergic therapy. This increases the diagnostic accuracy and reduces stigma. [13]

Table 2. Where hyperbulia (as a symptom) is most common

Context	Typical manifestations	Ratings/Notes
Mania in bipolar disorder	Increased goal-oriented activity, risk, impulsive decisions	The criterion for mania/hypomania is “increased activity/energy.” [14]
Behavioral variant of FTD	Disinhibition, hyperorality, impulsivity	Often, with an elderly onset, memory is relatively preserved early. [15]
Dopamine agonists	Gambling, hypersexuality, shopping, overeating	Risk ↑ with D3-agonists, effect is dose-dependent. [16]

Reasons

Biological mechanisms across various disorders converge on the "recalibration" of motivational systems. In mania, this is a general hyperactivation of the behavioral approach: an increase in dopamine and noradrenergic "energy," an acceleration of associative processes, and a strengthening of the "goal." This is why the criteria for mania and hypomania in the DSM-5/ICD-11 include abnormally increased activity/energy and purposefulness. [17]

In dopaminergic therapy (Parkinson's disease, prolactinoma), hyperbulia and related impulse-control disorders are explained by sensitization of the "want" system (incentive salience): the drug enhances "reinforcement expectation," particularly through D3 receptors in the ventral striatum. The person begins to pathologically "want" the activity/reward, even if "liking" has not increased. [18]

In the behavioral variant of frontotemporal degeneration, the frontal networks of inhibition and social control are dominant: damage to the orbitofrontal/ventromedial cortex reduces inhibition, and damage to the anterior temporal regions biases emotional evaluation. This leads to impulsivity, hyperorality, dietary changes, and the pursuit of immediate reward. [19]

Psychosocial factors (stress, sleep deprivation, access to rewards) exacerbate the severity of symptoms but are not the underlying causes. Therefore, lifestyle modifications are helpful but do not replace treatment of the underlying disorder or discontinuation/reversal of the offending medication. [20]

Risk factors

Table 3. What increases the likelihood of clinical "hyperbulia"

Group	Factors	Explanation
Nosological	Bipolar spectrum, bvFTD	Direct causes of increased motivation/disinhibition. [21]
Medicinal	Dopamine agonists (pramipexole, ropinirole, etc.)	Associated with gambling, hypersexuality, shopping, food. [22]
Neurological	Frontal lobe lesion, Klüver-Bucy syndrome	Hyperorality/hypersexuality, disinhibition. [23]
Psychosocial	Stress, lack of sleep, availability of stimuli	They increase the severity and accelerate the escalation. [24]

In patients with Parkinson's disease, the risk of impulse control disorders is higher in younger men, with higher doses of agonists, and with a personal/family predisposition to addictive patterns. Outside of Parkinson's disease, dopamine therapy for prolactinoma also increases the risk of similar disorders. [25]

In older adults, red flags include sudden disinhibition, impulsive spending, compulsive overeating, and “ridiculous” social behaviors against a background of decreased critical thinking – this is a reason to consider bvFTD and refer for a neurocognitive examination. [26]

Pathogenesis

Motivation consists of "like" and "want"; hyperbulia is a pathological acceleration of the "want" component (incentive salience), especially with dopaminergic sensitization. As a result, goals are experienced as urgent and exceptionally important, even if their value is questionable. [27]

In mania, an intensification of the "want" component is combined with affective elevation/irritability, decreased sleep, and overestimation of one's own abilities, which explains risky projects, spending, and sexual disinhibition. The DSM-5/ICD-11 criteria capture precisely this pattern—increased activity and energy as a necessary part of the episode. [28]

In frontotemporal degeneration, the mechanism is different: the "brakes" (frontal networks) are "released," so habitual inhibitions cease to function. This is closer to "disinhibition" than "euphoria" and can be combined with apathy in other areas. Hyperorality (craving sweets, oral stereotypies) is a characteristic feature. [29]

Drug-induced hyperbulia is a clear example of an “external” motivation switch: changing the dose/class of drug can quickly alleviate the symptom, which is critical for the safety of the patient and family. [30]

Symptoms

The key feature is an obsessive urge to "do something right now," a sense of unusual purposefulness, and a proliferation of projects and initiatives. Behavioral manifestations include endless multitasking, impulsive shopping, unusual sociability, risky decisions, and sleep disturbances "due to ideas." Sexually, this manifests as hypersexuality; eating behavior includes cravings for food/sweets, and late-night snacking. [31]

Mania is accompanied by elevated mood or irritability, decreased need for sleep, accelerated speech and thoughts, and grandiosity. These signs help distinguish mania from "simple enthusiasm." If psychotic symptoms (delusions, hallucinations) are present, seek immediate medical attention. [32]

In bvFTD, social inappropriateness, inappropriate humor, and a tendency to grab food/objects (“hypermetamorphosis” and hyperorality) are more often noticeable, while memory remains relatively intact for a long time - a typical trap for the family. [33]

Pathological cravings for gambling, shopping, food, online activities, or sex are common with dopamine agonists. Patients often conceal these episodes; active screening and open communication are part of the safety protocol. [34]

Classification, forms and stages

Clinically, it is convenient to distinguish: 1) affect-related hyperbulia (mania/hypomania), 2) frontal disinhibition (bvFTD, Kluver-Bucy syndrome), 3) drug-induced (secondary impulse-control disorders). These are not “types of hyperbulia,” but different pathways to the same behavioral phenotype. [35]

According to the course of the disease - episodic (mania/hypomania), progressive (neurodegeneration) and induced (during therapy), which directly determines the treatment tactics and prognosis. In episodic cases, the goal is remission and relapse prevention; in progressive cases - slowing down and safety; in induced cases - treatment modification. [36]

Staging: the prodrome may appear as a "rising initiative," followed by obvious disinhibition and impaired control; after treatment, stabilization with residual vulnerability to triggers (insomnia, stress, stimuli). It is helpful to discuss this with the patient and family. [37]

Table 4. Clinical "portraits"

The Path to Hyperbulia	Main features	First thought about tactics
Mania/hypomania	Mood elevation/irritability, energy, risk-taking	Normotimics, antipsychotics, sleep, psychoeducation. [38]
bvFTD/Kluver-Bucy	Disinhibition, hyperorality, social inappropriateness	Neurologist/Cognitive Center, Security, Guardianship. [39]
Drug-induced	Gambling/hypersexuality/shopping/eating in the background of YES	Review of dopaminergic therapy, ICD screening. [40]

Complications and consequences

Immediate risks include financial losses, debt obligations, legal problems, sexual risks, injuries, and conflicts. Mania can lead to dangerous decisions (loans, speeding, impulsive travel), bvFTD can lead to social and domestic incidents, and medication-induced depression can lead to the destruction of family finances and relationships. [41]

Medical consequences include exhaustion from sleep deprivation, exacerbation of somatic diseases, weight gain (hyperorality), and comorbid depressions "on the decline." For the family, this includes burnout and secondary stress. Early referral to a specialist reduces the "cost" of the episode. [42]

In Parkinson's disease and prolactinoma, the consequences of impulse control disorders often remain hidden unless specifically asked by the physician. Routine screening and patient education prior to treatment reduce the scope of problems and improve trust. [43]

It is legally important to document informed consent, discussion of side effects, and family contacts - this protects the patient and physician and facilitates joint decisions about changing therapy. [44]

When to see a doctor

If you or a loved one notices a sharp increase in goal-directed activity, impulsive spending, hypersexuality, compulsive overeating, or "idea racing," especially accompanied by sleep deprivation and irritability, this is a reason to urgently consult a psychiatrist/neurologist. The sooner treatment is started, the fewer the consequences. [45]

When taking dopamine agonists, any new cravings for gambling, shopping, sex, or food require immediate notification to the treating physician: a dose/medication adjustment is most often helpful. Stopping medications on your own is dangerous—a plan is needed. [46]

In older adults with sudden disinhibition and changes in habits (especially eating habits), it is important to exclude bvFTD and other neurological causes: cognitive assessment and neuroimaging are prescribed as indicated. [47]

If there is a safety risk (aggressive driving, suicidal thoughts while in remission, conflicts), seek emergency medical help. This is a medical necessity, not a "characteristic." [48]

Diagnostics

The first step is a clinical interview: what exactly is "pulling" you, how long does the increase in activity last, how have your sleep, money, sexuality, diet, and social interactions changed, and what has happened with medications. The doctor clarifies triggers, risk factors, and family reactions, and analyzes whether the symptoms meet the criteria for mania/hypomania. [49]

The second step is to determine the underlying medical condition. If there is an affective syndrome with elevated mood/irritability and increased energy/activity, consider mania/hypomania (ICD-10 F30/ICD-11 bipolar spectrum disorder). If the patient is elderly and exhibits dysinhibition and hyperorality, screen for bvFTD (neurologist, neuropsychologist). If symptoms began after starting dopamine agonists, check for secondary impulse control disorder (ICD-11 6E66). [50]

The third step is basic examinations as indicated: a complete blood count/biochemistry, thyroid function (to exclude thyrotoxicosis as a mimic of disinhibition), screening for toxic effects, and, if neurodegeneration is suspected, neuroimaging and cognitive testing. For drug-induced cases, a review of the entire list of medications is required. [51]

The fourth step is scales and monitoring: for the bipolar spectrum, severity assessment (e.g., using clinical scales at the site); for impulse control, questionnaires used in Parkinson's (QUIP, etc.), and recording financial/behavioral outcomes. This helps to monitor dynamics and legally document decisions. [52]

Table 5. Diagnostic route

Step	What are we doing?	For what
Clinical interview	We'll take a closer look at cravings, sleep, risks, and medications.	Identify a nosology instead of the empty label “hyperbulia.” [53]
Nosological fork	Mania/hypomania vs bvFTD vs medication form	Determines treatment and prognosis. [54]
Laboratory and instrumental department	TSH, general clinical, as indicated by MRI/CT	Exclude somatic mimicry and neurodegeneration. [55]
Screenings by context	QUIP, behavioral checklists	Monitoring and documentation. [56]

Differential diagnosis

Distinguish hyperbulia associated with mania from hyperthyroidism: thyrotoxicosis has more somatic symptoms (weight loss, tremors, sweating, tachycardia), anxiety without the characteristic affective "elevation" and without the typical increase in purposeful social/sexual activity. Thyroid tests resolve the issue. [57]

Distinguish from addictive disorders: in the drug-induced form, the trigger is dopamine agonists, and the spectrum of behavior is often polymorphic (gambling + shopping + food/sex). The key here is a reassessment of therapy, not just psychotherapy. [58]

Distinguish from neurodevelopmental hyperactivity/impulsivity (e.g., in adults with ASD/ADHD): there, symptoms are stable from childhood, without affective "waves" and without a clear culturally/medication-induced trigger. Approaches are different. [59]

Distinguish from frontal apathy/abulia: paradoxically, bvFTD can combine apathy in "boring" areas with disinhibition in "pleasant" ones. Observation in several contexts and questioning loved ones can help avoid mistakes. [60]

Table 6. "Similar - but different"

State	Which makes me think	The key to distinction
Mania	Mood lift/irritability + energy	Criteria for mania/hypomania, episodicity. [61]
Drug-induced ICD	Start/gain after YES	Dose/class association, polymorphism. [62]
bvFTD	Old age, hyperorality, disinhibition	Neurology/neuropsychology, MRI as indicated. [63]
Hyperthyroidism	Tachycardia, weight loss, tremor	TSH/T4 free, no typical euphoria. [64]

Treatment

The fundamental principle: treat the cause, not the symptom. If hyperbulia is part of the manic spectrum, the first line is stabilization of affect and activity: mood stabilizers (lithium, valproate, as indicated) and/or second-generation antipsychotics, sleep normalization, stimulus restriction, and family psychoeducation. Decisions are made by the physician, taking into account the patient's physical condition, pregnancy, drug interactions, and the desired side effect profile. [65]

During mania, it's critical to restore sleep: behavioral measures (strict bedtime, darkness, avoiding gadgets) and, if necessary, short-term supervised sleep medications. Sleep simultaneously reduces affective "overheating" and motivational "drive," reducing impulsivity and risk. Financial security is also important: temporary control of cards/online purchases by agreement with family. [66]

Psychoeducation and CBT modules after the acute phase of mania have subsided help identify the "prodrome of mania" (the first hours/days of increased initiative, decreased sleep, "great ideas") and introduce a self-help plan (contacting a doctor, increasing sleep therapy, "freezing" major decisions for 72 hours). This simple framework significantly reduces the cost of relapse. [67]

If hyperbulia is secondary to dopamine therapy, the key is treatment modification: dose reduction, switching from an agonist to levodopa or other regimens, a multidisciplinary decision by a neurologist/endocrinologist and psychiatrist. Evidence shows that agonists, especially D3-affinity agonists, are associated with gambling/hypersexuality/shopping; substitution often leads to symptom relief. Short-term use of antipsychotics/selective serotonin reuptake inhibitors is also possible, depending on individual indications. [68]

An open discussion with the patient and family is essential before starting dopamine agonists: "What are impulse control disorders?", what signs to monitor, and who to report. Some centers use short questionnaires (such as QUIP) before and after starting therapy. This not only improves safety but also strengthens the alliance. [69]

For bvFTD, drug therapy is symptomatic: selective serotonin reuptake inhibitors are sometimes used to reduce impulsivity and eating disinhibition; antipsychotics are used cautiously and only under strict indications (risk of side effects in the elderly). The main focus is environmental modification (daily structure, control of access to money and online purchases, safe kitchen), support for caregivers, and social services. [70]

In all scenarios, behavioral "safety measures" are helpful: agreements not to make large purchases or sign contracts without a 24-72-hour pause; card limits; disabling autofill on websites; timeouts before "hot" activities; sleep schedules and daily "default routines." These simple steps mitigate the damage while basic therapy gains momentum. [71]

Psychotherapeutic approaches depend on the underlying medical condition. After stabilizing mania, preventative modules (recognizing triggers, working with rhythms, and managing decisions), family therapy, and financial hygiene skills training are recommended. For medication-induced cases, motivational counseling and cognitive-behavioral techniques for gambling/shopping/binge eating are recommended, but medication adjustments remain the priority. [72]

Legal and social security: If impulsiveness is pronounced, it may be advisable to temporarily limit access to credit, delegate control of large transactions to a trusted person, set up bank notifications, and discuss a safe schedule with your employer. These are not punitive measures, but a bridge to restoring autonomy after stabilization. [73]

Finally, a recovery plan: after the hyperbulic phase, some patients experience fatigue and depressive symptoms. It's important to have contact information for help in advance, discuss suicide risk prevention, and ensure a smooth transition to therapy. A systematic post-episode debriefing with the doctor and family is the best way to prevent relapse. [74]

Prevention

Primary prevention is impossible (we can't "vaccinate" the reward system), but the risk of escalation can be reduced. For the bipolar spectrum, this includes regular sleep, a stable routine, limiting stimulants and "big" decisions during periods of heightened arousal; and early contact with a doctor at the first signs of increased activity. [75]

In dopaminergic therapy, informed consent, initial and periodic ICD screenings, and a hotline for the patient and family in the event of cravings for gambling/shopping/sex/food are provided. Preliminary financial limits and family agreements are part of prevention. [76]

In older adults, regular cognitive and behavioral screening for suspected bvFTD, early involvement of social services, and legal support for the family (powers of attorney, access to bank accounts if necessary) are recommended. This can mitigate the consequences even as the disease progresses. [77]

Cross-cutting measures include digital hygiene (minimizing "trigger" sites, delaying purchases), sleep and activity diaries, and a "24/72-hour rule" for decisions. These routine "little things" have a big cumulative effect. [78]

Forecast

The prognosis is determined by the underlying cause. In the bipolar spectrum, modern pharmacotherapy and psychoeducation can achieve remission and a return to previous levels of functioning, although relapses are possible – their frequency decreases with adherence to treatment and regimen. [79]

In drug-induced impulse control disorders, the prognosis is good with early recognition: adjustment of dopamine therapy often leads to symptom regression within weeks or months. Delay in reassessment increases the "cost" of the episode. [80]

In bvFTD, the prognosis is related to the underlying disease (progressive), but even here it is possible to significantly reduce risks, improve quality of life and reduce the severity of behavioral problems with competent environmental and symptomatic therapy. [81]

Cross-sectional conclusion: the sooner we move away from the label of “hyperbulia” to a specific diagnosis and route, the better the outcome – medical, social and financial. [82]

FAQ

Is hyperbulia a diagnosis?
No. It's a descriptive term for "an excessively strong craving/urge." The underlying condition is diagnosed and treated: mania, bvFTD, drug-induced impulse control disorder, etc. [83]

Which ICD codes should be used?
For mania - ICD-10 F30.*, ICD-11 bipolar spectrum disorder (6A60). For drug-induced cases - ICD-11 6E66 "secondary impulse-control disorder syndrome." For bvFTD - dementia categories with behavioral symptoms. [84]

Is it true that dopamine agonists "turn people into compulsive gamblers"?
The risk of impulse control disorders is indeed increased, especially with D3 agonists; this is reversible with a change in therapy. It is important to inform patients in advance and actively ask about symptoms. [85]

How can you differentiate hyperbulia from "just too much energy"?
Focus on control and consequences: impulsive spending, risk-taking, decreased sleep without fatigue, hypersexuality, conflicts, and "grand plans" are clinical markers, especially if they arise suddenly or in response to medication. [86]

What should the family do right now?
Limit access to large sums of money/loans, implement the "24/72 hour rule" for expensive decisions, improve sleep, contact a doctor, and discuss medications. If there are safety risks, seek emergency care. [87]